Effect of intravenous gentamicin on urinary calcium excretion in newborns
Abstract
Background Studies in newborns and animals have shown that gentamicin increases urinary calcium excretion. New recommendation for gentamicin in newborns is administered intravenously 36-48 hourly. Subsequent to this new recommendation, there have been no further studies on the effects of extended gentamicin dosage on urinary calcium excretion in newborns.
Objective To assess the effect of intravenous gentamicin on urinary calcium excretion in newborns.
Methods This pretest – posttest study was done in the Neonatology Division of Prof. DR. R. D. Kandou Hospital, Manado, from August to November 2013. Subjects were full-term newborns who received intravenous gentamicin every 36 hours and whose parents provided informed consent. We excluded newborns with asphyxia and cardiovascular shock, also those who received diuretics or steroids. Urine spot collection was done before, after the first dose, and after the second dose of intravenous gentamicin. Urinary calcium and creatinine levels were measuerd. Urine calcium excretion was defined as the ratio of urinary calcium to creatinine level.
Results Of 28 newborns, there were 16 males and 12 females. The median of urine calcium creatinine ratio before intravenous gentamicin was 0.021 (range 0.004 to 0.071) mg/mg. After first dose of gentamicin, the median ratio was 0.043 (range 0.009 to 0.156) mg/mg, and after the second dose of gentamicin, the median ratio was 0.144 (range 0.015 to 1.160) mg/mg.
Conclusion There is a significant increase in urinary calcium excretion after the first and second doses of intravenous gentamicin. Furthermore, a cumulative effect of gentamicin on urinary calcium excretion is observed after the second dose.Â
References
Pacifici GM. Clinical pharmacokinetics of aminoglycosides in the neonate: a review. Eur J Clin Pharmacol. 2009;65:419–27.
Koo WWK, Tsang RC. Calcium and magnesium homeostasis. In: MacDonald MG, Seshia MMK, Mullet MD, editors. Avery’s neonatology: pathophysiology and management of the newborn. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 848-75.
Fary R, Smith R. Neonatal pharmacopoeia. Melbourne: Royal Womens Hospital; 2005. p. 48-9.
Nagai J, Takano M. Molecular aspects of renal handling of aminoglycosides and strategies for preventing the nephrotoxicity. Drug Metab Pharmacokinetics. 2004;19:159–70.
Ward DT, Maldonado-Perez D, Hollins L, Riccardi D. Aminoglycosides induce acute cell signaling and chronic cell death in renal cells that express the calcium-sensing receptor. J Am Soc Nephrol. 2005;16:1236–44.
Nagai J, Saito M, Adachi Y, Yumoto R, Takano M. Inhibition of gentamicin binding to rat renal brush-border membrane by megalin ligands and basic peptides. J Control Release. 2006;112;43–50.
Kwak JO, Kwak J, Kim HW, Oh KJ, Kim YT, Jung SM, et al. The extracellular calcium sensing receptor is expressed in mouse mesangial cells and modulates cell proliferation. Exp Mol Med. 2005;37:457–65.
Alexandridis G, Liberopoulos E, Elisaf M. Aminoglycoside induced reversible tubular dysfunction. Pharmacology. 2003;67:118–20.
McLarnon S, Holden D, Ward D, Jones M, Elliot A, Ricardi D. Aminoglycoside antibiotics induce pH-sensitive activation of the calcium-sensing receptor. Biochem Biophys Res Commun. 2002;297:71–7.
Giapros VI, Cholevas VI, Andronikou SK. Acute effects of gentamicin on urinary electrolyte excretion in neonates. Pediatr Nephrol. 2004;19:322–5.
Chiruvolu A, Engle WD, Sendelbach D, Manning MD, Jackson GL. Serum calcium values in term and latepreterm neonates receiving gentamicin. Pediatr Nephrol. 2008;23:569–74.
Giapros VI, Andronikou SK, Cholevas VI, Papadopoulou ZL. Renal function and effect of aminoglycoside therapy during the first ten days of life. Pediatr Nephrol. 2003;18:46–52.
Jackson GL, Sendelbach MD, Stehel EK, Baum M, Manning WB, Engle WD. Association of hypocalcemia with a change in gentamicin administration in neonates. Pediatr Nephrol. 2003;18:653–6.
Lee CT, Chen HC, Ng HY, Lai LW, Lien YH. Renal adaptation to gentamicin-induced mineral loss. Am J Nephrol. 2012;35:279–86.
Tugay S, Bircan Z, Caglayan C, Arisoy AE, Gokalp AS. Acute effects of gentamicin on glomerular and tubular functions in preterm neonates. Pediatr Nephrol. 2006;21:1389-92.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Accepted 2015-11-24
Published 2015-07-31
